USA
Acceder
Cotización de BioCryst Pharmaceuticals, Inc. (BCRX) hoy en tiempo real
Análisis técnico y gráfico histórico de BioCryst Pharmaceuticals, Inc.
Análisis fundamental y estadísticas clave de BioCryst Pharmaceuticals, Inc.
Ficha de BioCryst Pharmaceuticals, Inc. (BCRX)
| Ticker | BCRX |
|---|---|
| ISIN | US09058V1035 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Análisis financiero de BioCryst Pharmaceuticals, Inc.
Resumen financiero e información corporativa de BioCryst Pharmaceuticals, Inc.
Ratios de valoración: PER, EV/EBITDA y métricas de BioCryst Pharmaceuticals, Inc.
Márgenes de rentabilidad y Cash Flow de BioCryst Pharmaceuticals, Inc.
BPA, Dividendos y Valor Contable: Métricas por acción de BioCryst Pharmaceuticals, Inc.
Solvencia y deuda: Análisis del balance de BioCryst Pharmaceuticals, Inc.
Ratios de liquidez y Test Ácido: Capacidad de pago de BioCryst Pharmaceuticals, Inc.
Invertir en BioCryst Pharmaceuticals, Inc. en 2026: Preguntas frecuentes
¿Qué es BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II clinical trial for complement-mediated disease...
¿En qué sector opera BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. opera en el sector Healthcare, industria Biotechnology.
Otras acciones del sector Atención sanitaria